Profil
Johannes C Scholtes has been Chairman & Chief Strategy Officer at ZyLAB North America LLC since 1989.
Since 2024, Dr. Scholtes has also been a Venture Partner at Endeit Capital BV.
Dr. Scholtes graduated from Delft University of Technology in 1987 and earned a doctorate from the University of Amsterdam in 1993.
Postes actifs de Johannes Scholtes
| Sociétés | Poste | Début |
|---|---|---|
ZyLAB North America LLC
ZyLAB North America LLC Information Technology ServicesTechnology Services Provides information technology services | Président | 01/01/1989 |
Endeit Capital BV
Endeit Capital BV Investment ManagersFinance Endeit Capital invests in companies located across Europe primarily in Germany, the Netherlands and Sweden. The firm targets companies operating across a broad range of sectors and industries. It provides financing for early and later stage capital requirements with an investment EUR 5 -20 million. | Private Equity Investor | 01/11/2024 |
Formation de Johannes Scholtes
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
University of Amsterdam
University of Amsterdam Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ZyLAB North America LLC
ZyLAB North America LLC Information Technology ServicesTechnology Services Provides information technology services | Technology Services |
Delft University of Technology
Delft University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Endeit Capital BV
Endeit Capital BV Investment ManagersFinance Endeit Capital invests in companies located across Europe primarily in Germany, the Netherlands and Sweden. The firm targets companies operating across a broad range of sectors and industries. It provides financing for early and later stage capital requirements with an investment EUR 5 -20 million. | Finance |
















